X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | ALKS | Parisi Samuel Joseph | VP, Finance (Interim PAO) | S - Sale+OE | $35.69 | -1,327 | 7,717 | -15% | -$47,361 | |||||
| DM | 2025-02-12 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.92 | -349,340 | 57,875 | -86% | -$11,848,975 | |||||
| D | 2025-01-30 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $32.05 | -100,918 | 44,290 | -69% | -$3,234,382 | |||||
| D | 2024-12-09 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $32.07 | -61,151 | 47,576 | -56% | -$1,961,406 | |||||
| D | 2024-12-09 | ALKS | Laurencin Cato T | Dir | S - Sale+OE | $31.85 | -2,691 | 23,013 | -10% | -$85,708 | |||||
2024-12-05 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale | $31.50 | -9,221 | 59,730 | -13% | -$290,462 | ||||||
2024-12-04 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale | $30.77 | -14,349 | 68,951 | -17% | -$441,550 | ||||||
2024-11-27 | ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | S - Sale | $29.15 | -5,208 | 60,703 | -8% | -$151,813 | ||||||
| D | 2024-11-11 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $30.08 | -58,996 | 83,300 | -41% | -$1,774,576 | |||||
2024-11-06 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale | $29.53 | -10,471 | 99,238 | -10% | -$309,169 | ||||||
2024-03-18 | ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | S - Sale | $28.10 | -10,417 | 65,911 | -14% | -$292,740 | ||||||
| D | 2024-02-27 | ALKS | Parisi Samuel Joseph | VP, Finance (Interim PAO) | S - Sale+OE | $29.65 | -2,559 | 7,717 | -25% | -$75,874 | |||||
| D | 2024-02-15 | ALKS | Laurencin Cato T | Dir | S - Sale+OE | $31.85 | -2,690 | 15,169 | -15% | -$85,677 | |||||
| D | 2023-06-08 | ALKS | Laurencin Cato T | Dir | S - Sale+OE | $31.85 | -2,638 | 7,479 | -26% | -$84,020 | |||||
| D | 2023-06-07 | ALKS | Laurencin Cato T | Dir | S - Sale+OE | $31.50 | -2,800 | 7,479 | -27% | -$88,200 | |||||
| D | 2023-05-30 | ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | S - Sale+OE | $28.93 | -27,134 | 40,984 | -40% | -$784,862 | |||||
| D | 2023-05-09 | ALKS | Wysenski Nancy | Dir | S - Sale+OE | $31.24 | -41,250 | 27,071 | -60% | -$1,288,786 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |